HCM Q4 2020 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$61M+14.7% YoY

Gross Profit

-$42M-69.7% margin

Operating Income

-$59M-97.8% margin

Net Income

-$38M-62.7% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$724M

Total Liabilities

$205M

Stockholders' Equity

$484M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$53M	+14.7%
Gross Profit	-$42M	-$61M	+30.2%
Operating Income	-$59M	$101M	-158.9%
Net Income	-$38M	-$37M	-1.8%